{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:47:13Z","timestamp":1767016033817},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>The aim of this study was to evaluate the diagnostic utility of serum galactomannan (GM) positivity for invasive aspergillosis (IA) in children. Positive GM results between January 2015 and August 2017 were reviewed retrospectively in children with hematologic malignancies. Single and consecutive positive GM results were evaluated according to the different galactomannan index (GMI) (&gt;0.5, &gt;0.7, &gt;1.0 and &gt;1.5) values. There were 104 positive GM results of 70 patients. IA was identified in 29 patients (41.4%) (2 proven and 27 probable). For a single positive GMI of &gt;0.5, &gt;0.7, &gt;1.0, and &gt;1.5, the numbers were 104, 76, 57, and 32 and the positive predictive values (PPVs) were 39.4%, 43.2%, 47.2%, and 50.0%, respectively. The single GM positivity at different thresholds showed no difference between the IA and non-IA group (<jats:italic toggle=\"yes\">P<\/jats:italic>&gt;0.05). For 2 consecutive positive GMI values of &gt;0.5, &gt;0.7, &gt;1.0, and &gt;1.5, the numbers were 34, 20, 13, and 4, and the PPVs were 58.8%, 65.0%, 84.6%, and 100.0%, respectively. In the IA group, positivity was higher at all thresholds (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05). According to our findings, consecutive GM positivity has higher PPVs independently from the cutoff value chosen. In pediatric patients with high risk, consecutive sampling should be preferred.<\/jats:p>","DOI":"10.1097\/mph.0000000000001653","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T13:11:09Z","timestamp":1573737069000},"page":"e271-e276","source":"Crossref","is-referenced-by-count":5,"title":["Assessment of Serum Galactomannan Test Results of Pediatric Patients With Hematologic Malignancies According to Consecutive Positivity and Threshold Level in Terms of Invasive Aspergillosis Diagnosis: Cross-Sectional Research in a Tertiary Care Hospital"],"prefix":"10.1097","volume":"42","author":[{"given":"\u0130lknur","family":"\u00c7a\u011flar","sequence":"first","affiliation":[{"name":"Pediatric Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duygu","family":"\u00d6zkerim","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neryal","family":"Tahta","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"D\u00fczg\u00f6l","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuri","family":"Bayram","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beng\u00fc","family":"Demira\u011f","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuba H.","family":"Karapinar","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yelda","family":"Sorgu\u00e7","sequence":"additional","affiliation":[{"name":"Microbiology, Dr. Beh\u00e7et Uz Children\u2019s Hospital, \u0130zmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"G\u00f6zmen","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vecihe","family":"Dursun","sequence":"additional","affiliation":[{"name":"Microbiology, Dr. Beh\u00e7et Uz Children\u2019s Hospital, \u0130zmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye\u015fim","family":"Oymak","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"Vergin","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lker","family":"Devrim","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"R1-20230918","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.1542\/peds.2007-2117","article-title":"Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases","volume":"121","author":"Burgos","year":"2008","journal-title":"Pediatrics"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MPH.0000000000001027","article-title":"Invasive fungal disease in pediatric acute leukemia in the nontransplant setting: 8 years\u2019 experience from a tertiary care center in North India","volume":"40","author":"Das","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000196477","article-title":"Pulmonary aspergillosis: early diagnosis improves survival","volume":"62","author":"von Eiff","year":"1995","journal-title":"Respiration"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/14787210.2016.1242413","article-title":"Diagnosis of invasive fungal diseases in pediatric patients","volume":"14","author":"Pana","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/425317","article-title":"Utility of Aspergillus antigen detection in specimens other than serum specimens","volume":"39","author":"Klont","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R9-20230918","first-page":"CD007394","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"12","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422009","article-title":"Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance","volume":"190","author":"Marr","year":"2004","journal-title":"J Infect Dis"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation","volume":"15","author":"Groll","year":"2014","journal-title":"Lancet Oncol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jmii.2013.12.003","article-title":"Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children","volume":"49","author":"Dinand","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/pbc.24363","article-title":"Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients","volume":"60","author":"Choi","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2141.2004.05140.x","article-title":"Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients","volume":"126","author":"Maertens","year":"2004","journal-title":"Br J Haematol"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/jpids\/pix054","article-title":"Role of molecular biomarkers in the diagnosis of invasive fungal diseases in children","volume":"6","author":"Huppler","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2012.06828.x","article-title":"Application of diagnostic markers to invasive aspergillosis in children","volume":"1272","author":"Roilides","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12281-012-0127-5","article-title":"The role of biomarkers for diagnosis of and therapeutic decisions related to invasive aspergillosis in children","volume":"7","author":"Fisher","year":"2013","journal-title":"Curr Fungal Infect Rep"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/cid\/ciw592","article-title":"Galactomannan, beta-D-glucan, and polymerase chain reaction-based assays for the diagnosis of invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"63","author":"Lehrnbecher","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/514349","article-title":"Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay","volume":"44","author":"Maertens","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1439-0507.2008.01652.x","article-title":"Galactomannan on the stage: prospective evaluation of the applicability in routine practice and surveillance","volume":"53","author":"Tanriover","year":"2010","journal-title":"Mycoses"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.patbio.2011.10.011","article-title":"Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis","volume":"60","author":"Hadrich","year":"2012","journal-title":"Pathol Biol (Paris)"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/myc.12048","article-title":"Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies","volume":"56","author":"Jha","year":"2013","journal-title":"Mycoses"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2016.10.027","article-title":"Utility of the serum galactomannan assay for the diagnosis of invasive aspergillosis in children with acute lymphoblastic leukemia","volume":"54","author":"Avcu","year":"2017","journal-title":"Int J Infect Dis"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3855\/jidc.2110","article-title":"Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients","volume":"6","author":"Badiee","year":"2012","journal-title":"J Infect Dev Ctries"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jpids\/pis044","article-title":"Galactomannan antigen testing for diagnosis of invasive aspergillosis in pediatric hematology patients","volume":"1","author":"Fisher","year":"2012","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2010.01961.x","article-title":"Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy","volume":"55","author":"Mikolajewska","year":"2012","journal-title":"Mycoses"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3904\/kjim.2015.30.6.899","article-title":"Serum galactomannan levels in the diagnosis of invasive aspergillosis","volume":"30","author":"Okuturlar","year":"2015","journal-title":"Korean J Intern Med"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/08880018.2014.981900","article-title":"Serum galactomannan screening for diagnosis of invasive pulmonary aspergillosis in children after stem cell transplantation or with high-risk leukemia","volume":"32","author":"Gefen","year":"2015","journal-title":"Pediatr Hematol Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:48:40Z","timestamp":1695012520000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001653","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,12]]}}}